Literature DB >> 13867648

The pharmacological properties of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (Mebutamate, W-583), a new centrally acting blood pressure lowering agent.

F M BERGER, J F DOUGLAS, M KLETZKIN, B J LUDWIG, S MARGOLIN.   

Abstract

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13867648

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  6 in total

1.  To-day's Drugs.

Authors: 
Journal:  Br Med J       Date:  1963-04-13

2.  Antitetanus activity of central muscle relaxants.

Authors:  K P Bhargava; R K Srivastava
Journal:  Br J Pharmacol Chemother       Date:  1965-08

3.  Hypnotic properties of mebutamate: a comparative study of mebutamate, secobarbital and placebo in psychiatric patients.

Authors:  L Tetreault; P Richer; J M Bordeleau
Journal:  Can Med Assoc J       Date:  1967-08-19       Impact factor: 8.262

4.  CLINICAL EVALUATION OF A NEW ANTIHYPERTENSIVE AGENT: W583 (MEBUTAMATE).

Authors:  D A KAVELMAN; J A LEWIS
Journal:  Can Med Assoc J       Date:  1963-11-09       Impact factor: 8.262

5.  Effect of guanethidine, hemicholinium and mebutamate on the hypertensive response to eserine and catechol amines.

Authors:  V VARAGIC; N VOJVODIC
Journal:  Br J Pharmacol Chemother       Date:  1962-12

6.  THE MECHANISM OF THE PRESSOR RESPONSES TO PHYSOSTIGMINE IN THE RAT AND THEIR MODIFICATION BY MEBUTAMATE AND AMYLOBARBITONE.

Authors:  D DELLABELLA; A GANDINI; M PRETI
Journal:  Br J Pharmacol Chemother       Date:  1964-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.